A California-based technology startup has developed an augmented reality headset meant to help patients cope with macular degeneration.
Mitchael Freeman, COO of Ocutrx Vision Technologies, LLC, presented the products and discussed how wearable devices, smartphones and artificial intelligence are changing healthcare at the Medical Design & Manufacturing West Conference.
Freeman highlighted the Oculenz Advanced Macular Degeneration ARwear, which has patented technology that uses complex algorithms to reposition video pixels from blurred vision areas to adjacent areas that still have viable vision.
“The speed at which wearable technology is developing and proving its utility in the healthcare space is raising a lot of eyebrows internationally,” Freeman said. “The Ocutrx technology is aimed at both improving surgery protocols and outcomes as well as assisting patients with low vision conditions such as age-related macular degeneration, amblyopia and hemianopsia. But the reality is that our tech — and other wearable tech currently in our development — can and will be used for everything from general healthcare to fitness; from remote disease monitoring to in-home pharma testing; and into advanced surgical telemedicine — and the list goes on.”
Oculenz is available for pre-order now, with shipping expected by summer.
